Please login to the form below

Not currently logged in

Real-world evidence

Investigating the sources of evidence as best practice moves from being knowledge-based to evidence-based

Creative marketing and compliance

The challenge of addressing this fine balancing act

The new launch paradigm

The journey from capabilities excellence to effectiveness

Deal Watch October 2016

Medius Deal WatchAllergan, Astellas, AstraZeneca, Boehringer Ingelheim and Eli Lilly feature in this month's pharma deals round-up

Dispensing with the past

The pharma boards of the future


Communicating innovation to payers and policy makers

Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

Scale & Strategy: Essential tools for transforming the commercial model

Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and

Immuno-oncology's evolution: implications for pharma market researche

Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached

Driving adoption of Commercial Analytic solutions

Driving adoption of Commercial Analytic solutionsMeasuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge


Webinar: Customer engagement design

Customer engagement design pharma Webinar: Customer engagement design

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

Webinar: Become your customer’s chosen channel

Your customer now expects to access knowledge in any format and at any time that they desire. But how do you become the ever-present partner that they trust and value

Understanding the chronic disease patient journey in emerging markets

Infographic: Keeping tracking on track

Our best practice approach to tracking studies.

What does the Five Year Forward View mean for pharma?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.

Featured jobs

Subscribe to our email news alerts


Add my company
Four MSA

Four MSA creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal approach....